Tsumura & Co operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tsumura & Co with three other
companies in this sector in Japan:
Nippon Shinyaku Co Ltd
sales of 98.78 billion Japanese Yen [US$888.04 million]
of which 86%
was Pharmaceutical Products),
Kaken Pharmaceutical Co Ltd
(101.48 billion Japanese Yen [US$912.30 million]
of which 98%
was Pharmaceutical), and
KYORIN Holdings, Incorporation
(115.37 billion Japanese Yen [US$1.04 billion]
of which 95%
was Pharmaceutical Business).
Tsumura & Co reported sales of ¥114.95 billion (US$1.03 billion)
March of 2017.
increase of 2.1%
versus 2016, when the company's sales were ¥112.63 billion.
Sales at Tsumura & Co have increased during each of the previous five years
(and since 2012, sales have increased a total of 20%).